The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Loading articles...
Showing 9 / 1275 articles
More Americans are prioritizing meat for protein, with 75% seeing it as healthy—up from 64% in 2020. But experts like Tufts' Erin Hennessy caution against overfixating on meat amid industry pushes and RFK Jr.'s endorsements. Discover the health risks and smarter protein alternatives.
Eli Lilly's Foundayo, a groundbreaking once-daily oral GLP-1 pill for weight loss, is now shipping nationwide in the US following FDA approval. Backed by the ATTAIN trials, it delivered an average 27-pound loss at the highest dose. Discover access options, pricing, and what patients need to know.
New research from 23andMe reveals genetic variants in GLP1R that boost weight loss from GLP-1 drugs by up to 3.3 pounds. GIPR mutations increase vomiting risk on tirzepatide. Meanwhile, semaglutide's heart benefits appear independent of weight loss, opening doors to precision dosing.
GLP-1 medications like Ozempic are transforming lives but also sparking a spending frenzy far beyond drug costs. From gym memberships to combat muscle loss to entire wardrobe replacements, users like sales executive Kelly Freeman are spending $700-$1,000 monthly. Industries from fitness to plastic surgery are reaping windfalls.
Amazon is revolutionizing access to GLP-1 weight-loss drugs by launching same-day delivery for Foundayo through Amazon Pharmacy in nearly 3,000 cities. Patients can now order with a valid prescription, check real-time availability, and get medication home-delivered faster than traditional options. This move cuts treatment barriers from prescription to doorstep.
Ozempic and similar weight-loss drugs like tirzepatide work better for some patients due to specific genetic variants affecting GLP-1 and GIP receptors, a new 23andMe study shows. While average users lose 10% body weight, those with certain gene copies shed up to 1.5kg more—or face higher nausea and vomiting risks. This research uncovers why responses vary widely.
Rosie O'Donnell, who started Mounjaro in January 2023 for diabetes management, has become a poster child for 'Mounjaro face' after shedding 10 pounds quickly. Side-by-side photos from September 2022 and October 2025 highlight sagging skin around her mouth and cheeks, with expert analysis noting a grayish hue. Despite cosmetic changes, she's embracing the weight loss benefits.
Real Housewives of Salt Lake City star Heather Gay has shared her Ozempic-assisted weight loss journey, crediting the GLP-1 injection for noticeable results after initial slow progress. Losing around 30 pounds amid social pressures from friends' transformations, she called it a 'long, overdue glow-up' thanks to modern medicine. Despite Ozempic face rumors, Gay remains open about her experience.
India's semaglutide market is heating up with more than 50 brands poised to launch post-patent. But experts warn of a measured rollout due to the drug's intricate manufacturing demands. Inside the scramble for affordable GLP-1 access in a diabetes hotspot.
